Is telehealth allowed to prescribe Ozempic in Florida?

If you’ve been researching weight loss medications like Wegovy, Ozempic, or Mounjaro, you’ve probably wondered: Can I actually get these prescribed through telehealth? The short answer is yes—and for most people, it’s completely legal and safe. But the details matter, especially depending on where you live.

With telehealth expanding rapidly and GLP-1 medications becoming household names, understanding the rules can help you access treatment confidently and avoid potential pitfalls. This guide breaks down everything you need to know about getting weight loss medication through telehealth in 2025.

Understanding Telehealth Prescribing Rules for Weight Loss Medications

Federal Law: The Ryan Haight Act and What It Means for You

Here’s the critical thing to understand: GLP-1 weight loss medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This distinction is crucial because it means the federal Ryan Haight Act—which requires an in-person visit before prescribing controlled drugs via telemedicine—doesn’t apply to these medications.

Since the COVID-19 pandemic, the Drug Enforcement Administration (DEA) has extended temporary flexibilities for prescribing controlled substances through telehealth (currently through December 31, 2025). However, these extensions primarily affect medications like Adderall or buprenorphine. For weight loss medications, there has never been a federal barrier to telehealth prescribing—they’ve always been eligible for telemedicine.

Bottom line: Under federal law, a licensed healthcare provider can evaluate you online and electronically send a prescription for GLP-1 medications to your pharmacy, provided you meet medical criteria.

State Regulations: Where Things Get Specific

While federal law provides the foundation, state laws add specific requirements that can vary significantly. Some states require an initial in-person exam, while others allow the entire treatment journey to happen virtually. Let’s explore what this looks like across the country.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Requirements for Weight Loss Medications

States with No In-Person Visit Required

California, Connecticut, Illinois, New York, Pennsylvania, and Washington are among the states where you can complete your entire weight loss medication journey via telehealth. These states have embraced telemedicine fully, allowing licensed providers to conduct comprehensive evaluations through video consultations.

In California, nurse practitioners can even practice independently after gaining three years of experience, making access to care particularly streamlined. Similarly, Washington has been a pioneer in telehealth adoption, with full independent practice authority for nurse practitioners.

Connecticut takes a holistic approach, requiring that weight loss prescriptions include behavioral counseling and a diet/exercise plan—but all of this can be done through telehealth platforms.

States Requiring Initial In-Person Exams

Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, and Virginia require at least one in-person visit before or shortly after beginning telehealth treatment.

Texas, for example, has particularly strict oversight. The state’s medical board generally expects an initial in-person physical exam before prescribing weight loss medications via telehealth. Additionally, nurse practitioners must work under physician delegation agreements—they cannot prescribe independently.

New Jersey and Virginia go even further, requiring comprehensive initial evaluations including:

• Physical examination
• Laboratory work (metabolic panel, liver function tests)
• Detailed medical history
• Personalized diet and exercise plan
• Psychological screening

Virginia also mandates a follow-up visit within 30 days of starting therapy, ensuring close monitoring during the critical early phase of treatment.

Florida’s Unique Requirements

Florida allows telehealth prescribing but imposes specific conditions for obesity medications:

• BMI must be ≥30 (or ≥27 with weight-related comorbidities)
• Follow-up visits required at least every three months
• Documentation of lifestyle modification attempts

While Florida doesn’t require an initial in-person exam, the regular follow-up requirement ensures ongoing medical oversight throughout your treatment.

Who Can Prescribe Weight Loss Medications via Telehealth?

Physicians (MDs and DOs)

All states allow medical doctors and doctors of osteopathy to prescribe GLP-1 medications through telehealth, provided they’re licensed in the state where you’re physically located. This is straightforward and universally accepted.

Nurse Practitioners and Physician Assistants

The prescribing authority for nurse practitioners (NPs) and physician assistants (PAs) varies significantly by state:

Full Independent Practice (34+ states including DC): In states like Arizona, California, Colorado, Hawaii, Maryland, Minnesota, New Mexico, New York, Oregon, Rhode Island, and Washington, nurse practitioners can prescribe weight loss medications independently after meeting experience requirements (typically 2-3 years of supervised practice).

Collaborative Practice: States like Florida, Georgia, Illinois, Missouri, Ohio, Pennsylvania, and Tennessee require NPs and PAs to work under collaborative agreements or protocols with physicians. They can still prescribe GLP-1 medications, but must have physician oversight.

Recent Changes: Georgia passed legislation in 2024 allowing NPs and PAs to prescribe Schedule II controlled substances under physician delegation for the first time—a significant expansion of scope that reflects the nationwide trend toward greater NP autonomy.

At Klarity Health, we work exclusively with licensed, credentialed providers who are authorized to practice in your state. Whether you see an MD, DO, NP, or PA through our platform, you can trust they’re operating within all legal and ethical guidelines.

The Medications: Wegovy, Ozempic, and Mounjaro

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition.

Telehealth Prescribing: Fully legal in all states (subject to state-specific requirements above).

Key Points:

• Requires weekly self-injection
• Treatment should include lifestyle modifications
• Typical starting dose is 0.25mg, gradually increased over 16-20 weeks
• Common side effects include nausea, diarrhea, and constipation

Important Note: The FDA banned routine compounding of semaglutide for weight loss effective May 2025. Only FDA-approved brand-name Wegovy or its authorized generics should be prescribed. Be cautious of services offering ‘compounded semaglutide’—these may not be legal or safe.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for Type 2 diabetes, commonly used off-label for weight loss.

Telehealth Prescribing: Legal, but providers must document off-label use rationale and obtain informed consent.

Key Considerations:

• Same active ingredient as Wegovy, but lower maximum dose
• Should not be combined with Wegovy or other semaglutide products
• Requires clear documentation when prescribed for weight loss rather than diabetes
• May be more readily available during Wegovy shortage periods

Mounjaro (Tirzepatide)

FDA Status: Approved for Type 2 diabetes; the obesity-specific formulation is marketed as Zepbound.

Telehealth Prescribing: Fully legal for appropriate patients.

Key Points:

• Works on both GLP-1 and GIP receptors (dual action)
• Often produces greater weight loss than semaglutide in clinical trials
• Similar side effect profile to other GLP-1 medications
• Requires patient training on proper injection technique

What to Expect During a Telehealth Weight Loss Consultation

The Evaluation Process

Reputable telehealth providers follow a structured evaluation process:

Medical History Review:

• Current and past medical conditions
• Medication list and allergies
• Previous weight loss attempts
• Family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Current Health Assessment:

• Height and weight (for BMI calculation)
• Blood pressure
• Recent laboratory results if available
• Weight-related comorbidities (diabetes, hypertension, sleep apnea, etc.)

Risk Screening:

• History of pancreatitis
• Gallbladder disease
• Gastrointestinal disorders
• Pregnancy status and plans
• Mental health conditions (including eating disorders)
• Current medications that might interact

Video Consultation:Most states require a live, synchronous video visit (not just a questionnaire) to establish the patient-provider relationship. During this visit, your provider will:

• Review your health information
• Discuss treatment goals and realistic expectations
• Explain how the medication works
• Detail potential side effects and how to manage them
• Outline the treatment plan, including lifestyle modifications
• Answer your questions

Treatment Planning and Informed Consent

Before prescribing, your provider should ensure you understand:

• Gradual weight loss: These medications typically produce 10-15% body weight loss over 6-12 months—not overnight results
• Lifestyle commitment: Medication works best when combined with dietary changes and increased physical activity
• Common side effects: Nausea, vomiting, diarrhea, constipation, and abdominal discomfort are common, especially when starting or increasing doses
• Serious but rare risks: Thyroid tumors (in animal studies), pancreatitis, gallstones, kidney problems
• Cost considerations: These medications can be expensive; understanding insurance coverage or out-of-pocket costs upfront prevents surprises

At Klarity Health, we believe in transparent pricing and accept both insurance and cash payment, giving you flexibility in how you access care.

Ongoing Monitoring and Follow-Up

Quality telehealth weight loss programs include regular follow-up:

First Month: Check-in within 2-4 weeks to assess:

• Tolerance to medication
• Side effect management
• Early response to treatment
• Any needed dose adjustments

Ongoing (Every 2-3 Months):

• Weight and BMI tracking
• Side effect monitoring
• Dose titration as needed
• Lab work review (metabolic panel, liver function)
• Lifestyle modification support
• Medication refills

Some states mandate specific follow-up timelines—for example, Florida requires visits every three months, and Virginia requires a 30-day check-in after starting therapy.

Eligibility Criteria: Who Qualifies for Weight Loss Medication?

Medical Requirements

Standard Criteria:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related comorbidity such as:
• Type 2 diabetes or prediabetes
• Hypertension
• High cholesterol
• Obstructive sleep apnea
• Cardiovascular disease
• Non-alcoholic fatty liver disease

Age: Typically 18 years or older (some medications now approved for adolescents 12+ with obesity)

Contraindications and Disqualifying Conditions

You may not be a candidate if you have:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or plans to become pregnant within 2 months
• History of severe pancreatitis
• Active gallbladder disease
• Severe gastrointestinal disorders (gastroparesis, inflammatory bowel disease)
• History of eating disorders (relative contraindication requiring careful evaluation)
• Diabetic retinopathy (requires caution and monitoring)

Common Misconceptions About Eligibility

Myth: ‘Anyone can get Ozempic online for cosmetic weight loss.’Reality: Legitimate telehealth providers carefully screen patients and only prescribe when medically appropriate. If you’re only slightly overweight without health complications, you’ll likely be advised to try lifestyle modifications first.

Myth: ‘These are just diet pills I can use short-term.’Reality: GLP-1 medications are intended for chronic weight management—meaning long-term use, often indefinitely. Weight regain commonly occurs if medication is stopped without ongoing lifestyle support.

Myth: ‘The medication alone will do all the work.’Reality: These medications are most effective when combined with dietary changes, increased physical activity, and behavioral support. They’re tools to help you succeed, not magic bullets.

Red Flags: How to Identify Questionable Telehealth Services

The popularity of weight loss medications has unfortunately attracted some unscrupulous providers. Watch out for these warning signs:

🚩 No Real Medical Evaluation

Red Flag: Services that guarantee a prescription before you’ve completed a medical evaluation, or that only require a brief questionnaire without a video consultation.

What’s Proper: A legitimate provider will require a comprehensive medical history, live video consultation, and may request recent lab work before prescribing.

🚩 Compounded or ‘Generic’ Semaglutide

Red Flag: Offers for significantly cheaper ‘compounded’ or overseas versions of semaglutide.

What’s Proper: As of May 2025, the FDA effectively banned routine compounding of semaglutide for weight loss. Only FDA-approved brand medications (Wegovy, Ozempic) or authorized generics should be prescribed. Compounded versions may lack quality control and could be dangerous.

🚩 No Follow-Up or Monitoring

Red Flag: Services that send you medication without scheduling follow-up appointments or providing access to ongoing care.

What’s Proper: Regular monitoring is essential for safety and effectiveness. Expect monthly check-ins initially, then every 2-3 months once stable.

🚩 Unclear Provider Credentials

Red Flag: You can’t easily verify who your provider is, what state they’re licensed in, or their qualifications.

What’s Proper: Legitimate telehealth platforms clearly display provider credentials and ensure they’re licensed in your state. At Klarity Health, provider availability and transparency are core values—you’ll always know who you’re working with.

🚩 Pressure Tactics or Unrealistic Promises

Red Flag: Marketing that promises dramatic weight loss (‘lose 30 pounds in 30 days!’), downplays side effects, or uses high-pressure sales tactics.

What’s Proper: Honest providers set realistic expectations, thoroughly discuss risks and benefits, and never pressure you into treatment.

Insurance Coverage and Cost Considerations

Insurance Coverage for Weight Loss Medications

Coverage varies widely:

Medicare: Currently does not cover weight loss medications (though this may change with pending legislation).

Commercial Insurance: Many plans now cover GLP-1 medications for weight loss, but typically with prior authorization requirements proving:

• Medical necessity (BMI criteria met)
• Previous weight loss attempts documented
• No contraindications
• Ongoing medical monitoring

Medicaid: Coverage varies by state; some states cover FDA-approved obesity medications, others don’t.

Typical Out-of-Pocket Costs

Without Insurance:

• Wegovy: $1,300-$1,500/month
• Ozempic (off-label): $900-$1,000/month
• Mounjaro/Zepbound: $1,000-$1,200/month

With Insurance:

• Copays typically $25-$50/month with prior authorization
• Some plans require step therapy (trying other treatments first)

Manufacturer Savings Programs:

• Novo Nordisk and Eli Lilly offer savings cards that can reduce costs
• Typically for commercially insured patients (not Medicare/Medicaid)
• May lower copays to as little as $25/month

At Klarity Health, we work with both insurance and cash-pay patients, providing transparent pricing upfront so there are no surprises. Our team can help navigate prior authorization processes and identify cost-saving options.

The Future of Telehealth Weight Loss Treatment

Regulatory Trends

Federal Level: The DEA’s telehealth flexibilities for controlled substances are extended through December 31, 2025. While this doesn’t directly affect GLP-1 medications (which aren’t controlled), it signals ongoing federal support for telemedicine expansion. Congress is considering the TREATS Act, which would permanently allow telehealth prescribing for certain medications, including those for substance use disorder and mental health.

State Level: The trend is clearly toward greater access and fewer barriers. In 2024-2025:

• Georgia expanded NP/PA prescribing authority
• Indiana and Michigan granted full practice authority to nurse practitioners
• 34+ states now allow independent NP practice
• Interstate licensure compacts continue to grow, making multi-state practice easier

What This Means for Patients: Expect telehealth options for weight loss medications to become even more convenient and accessible, with more providers able to serve you regardless of where you live.

Emerging Options

New Medications: Pharmaceutical companies are developing next-generation obesity medications, including:

• Oral GLP-1 medications (eliminating the need for injections)
• Triple-agonist medications targeting additional pathways
• Combination therapies for enhanced weight loss

Technology Integration: Future telehealth platforms may incorporate:

• Connected scales that automatically share weight data with providers
• Continuous glucose monitors for real-time metabolic feedback
• AI-powered nutrition and exercise coaching integrated with medication management
• Virtual reality support groups and behavioral therapy

Access and Equity Considerations

As telehealth weight loss treatment expands, ensuring equitable access remains important:

Geographic Barriers: Telehealth helps overcome rural healthcare deserts, but requires reliable internet access.

Cost Barriers: Even with telehealth, medication costs remain prohibitive for many. Advocacy continues for broader insurance coverage.

Health Literacy: Not everyone is comfortable with technology or navigating complex healthcare systems. Quality telehealth providers offer support for patients of all backgrounds and comfort levels.

State-Specific Comparison Table

Frequently Asked Questions

Q: Do I need to see the provider in person first?It depends on your state. California, Connecticut, Illinois, New York, Pennsylvania, and Washington allow the entire process via telehealth. States like Arkansas, Texas, Virginia, and several others require an initial in-person examination.

Q: Can nurse practitioners prescribe weight loss medications?Yes, in all states—but the level of independence varies. In states with full practice authority (like California, Washington, New York), NPs can prescribe independently. In others, they need physician collaboration or oversight.

Q: Are these medications covered by insurance?Many commercial insurance plans now cover FDA-approved weight loss medications like Wegovy, but usually require prior authorization. Medicare currently doesn’t cover them, and Medicaid coverage varies by state.

Q: How long will I need to take the medication?GLP-1 medications are intended for chronic, long-term use. Weight regain is common if you stop the medication without maintaining lifestyle changes. Your provider will discuss your individual treatment timeline.

Q: What if I experience side effects?Common side effects like nausea often improve over time or with dose adjustments. Your telehealth provider should be readily accessible to discuss side effects and make changes to your treatment plan as needed. Serious side effects require immediate medical attention.

Q: Can I get these medications from an online pharmacy or overseas?Only obtain medications from licensed U.S. pharmacies with a valid prescription. Medications from overseas sources or unregulated online pharmacies may be counterfeit, contaminated, or improperly stored.

Taking the Next Step: How to Get Started Safely

If you’re considering weight loss medication through telehealth, here’s how to proceed safely:

1. Verify Eligibility: Check whether your BMI and health status meet criteria for medical weight loss treatment.

2. Research Providers: Choose a legitimate telehealth platform with:

• Licensed, credentialed providers
• Clear pricing and policies
• Proper medical evaluation processes
• Ongoing monitoring and support
• Positive patient reviews

3. Prepare for Your Consultation:

• Gather your medical history and current medication list
• Know your current weight and height
• List any previous weight loss attempts
• Prepare questions about the treatment process

4. Understand State Requirements: Know whether your state requires an in-person visit and plan accordingly.

5. Budget Appropriately: Understand costs, insurance coverage, and available savings programs before starting.

6. Commit to the Process: These medications work best as part of a comprehensive approach including dietary changes, increased activity, and behavioral support.

How Klarity Health Can Help

At Klarity Health, we understand that navigating weight loss treatment can feel overwhelming. That’s why we’ve built a platform focused on accessible, transparent, and high-quality care:

Provider Availability: Our network of licensed physicians, nurse practitioners, and physician assistants are available when you need them, with convenient scheduling that fits your life.

Transparent Pricing: We believe you should know what care costs upfront. We accept both insurance and cash payment, giving you options that work for your situation.

Comprehensive Care: From initial evaluation through ongoing monitoring, we provide the full spectrum of support you need for successful weight management—not just a prescription.

Licensed in Your State: We ensure all providers are properly licensed and credentialed to practice in your state, meeting all legal requirements.

Patient-Centered Approach: Your goals, concerns, and individual circumstances guide your treatment plan. We’re here to support you, not pressure you.

Ready to explore whether telehealth weight loss treatment is right for you? Klarity Health makes it simple to get started with a consultation that fits your schedule and your budget.

Research Currency Statement

Verified as of: December 17, 2025

DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

⚠️ Flagged for follow-up: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws are constantly evolving; watch for any changes in 2026. FDA oversight on compounded GLP-1 medications tightened in 2025 – ensure compliance with current FDA guidance.

References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. Available at: www.dea.gov

2. COVID-era telehealth prescribing extended – Axios, November 18, 2024. Available at: www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing through December 31, 2025 – McDermott Will & Emery, November 18, 2024. Available at: www.mwe.com

4. Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs – Goodwin Procter LLP, March 27, 2024. Available at: www.goodwinlaw.com

5. Hims cuts 4% of workforce amid ban on weight-loss drug copies – Reuters, May 30, 2025. Available at: www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid